|
|
|
|
PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia
Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today honored Ron and Raychel Bartek for their dedicated work driving awareness of Friedreich's ataxia, a debilitating, life-threatening, rare disease.The...
|
|
|
PhRMA rare disorders
Contact: Kate Michael of Pharmaceutical Research and Manufacturers of America, +1-202-835-3460 WASHINGTON, March 18 /PRNewswire-USNewswire/ Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today honored Ron and Raychel...
|
|
|
PhRMA Honors Patient Advocates Ron and Raychel Bartek
Companies mentioned in this article: Pharmaceutical Research and Manufacturers of America WASHINGTON, March 18 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today honored Ron and Raychel...
|
|
|
PhRMA rare disorders
BC-PhRMA-rare-disorders To: NATIONAL EDITORS Contact: Kate Michael of Pharmaceutical Research and Manufacturers of America, +1-202-835-3460 WASHINGTON, March 18 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President...
|
|
|
PhRMA Honors Patient Advocates Ron and Raychel Bartek
WASHINGTON The Barteks are co-founders of the Friedreich's Ataxia Research Alliance, an organization dedicated to the pursuit of scientific research leading to treatments and a cure for the disease.However, they are more than advocates; they are...
|
|
|
Penwest Pharmaceuticals Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market
www.companiesandmarkets.com/Summary-Company-Profile/penwest-phar ..Penwest Pharmaceuticals Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key...
|
|
|
Penwest Pharmaceuticals Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released
Refer to a friend 2010-03-10 12:47:12 - Penwest Pharmaceuticals Co.- Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com Penwest Pharmaceuticals Co. - Pharmaceuticals & Healthcare -...
|
|
|
Santhera Pharmaceuticals Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released ..
Santhera Pharmaceuticals Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released Refer to a friend 2010-03-10 12:13:04 - Santhera Pharmaceuticals Holding AG - Pharmaceuticals & Healthcare - Deals and...
|
|
|
Santhera Pharmaceuticals Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new
www.companiesandmarkets.com/Summary-Company-Profile/santhera-pha ..Santhera Pharmaceuticals Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the...
|
|
|
Repligen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released
Refer to a friend 2010-03-10 12:37:01 - Repligen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com Repligen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances...
|
|
|
Repligen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report
www.companiesandmarkets.com/Summary-Company-Profile/repligen-cor ..Repligen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business...
|
|
|
Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009
Update on Cardium Therapeutics' plans for commercial development of GenerxCardium Therapeutics reported today that its Cardium Biologics division provided an update on plans ...Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara...
|
|
|
Santhera Pharmaceuticals Holding AG (CH) - Santhera Reports Strong 2009 Revenues of CHF 22.3m and Is Financed
- Santhera Pharmaceuticals (SIX: SANN) announced today the financial results for 2009 and updated on the development pipeline.The specialty pharmaceutical company recorded total revenues of CHF 22.3 million consisting of CHF 1.6 million net product sales...
|
|
|
Biotech Santhera slashes cash burn, cuts loss
* Reports narrower 2009 net loss of 26 mln Sfr ZURICH, Feb 26 (Reuters) - Swiss biotech Santhera (SANN.S Santhera had a major blow last year when its lead drug Catena, also known as idebenone, missed its main aim in a late-stage trial last year in Friedreich...
|
|
|
Skin of Friedreich's ataxia patients becomes stem cell source
Australian scientists have produced induced pluripotent stem cells from the skin Skin of Friedreich's ataxia patients becomes stem cell source.
|
